EDGAR Filing Documents for 0000320017-15-000066

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0000320017-15-000066

Filing Date

2015-08-06

Accepted

2015-08-06 17:04:35

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	s-32015shelf.htm	S-3	455585
2	EXHIBIT 4.5	exhibit45ti.htm	EX-4.5	418563
3	EXHIBIT 5.1	exh51phconsent.htm	EX-5.1	58714
4	EXHIBIT 23.1	exhibit231gtconsent.htm	EX-23.1	3237
	Complete submission text file	0000320017-15-000066.txt		937392

Mailing Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170

Business Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170 212-584-4171

Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)